AbbVie (ABBV) Work In Process (2012 - 2016)

AbbVie (ABBV) has reported Work In Process for 5 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2016.

• On a quarterly basis, Work In Process rose 4.81% year-over-year to $1.1 billion in Q2 2016; TTM through Jun 2016 was $1.1 billion, a 4.81% increase from a year earlier, with the FY2015 full-year figure at $1.1 billion, up 71.86% from the prior year.
• Work In Process was $1.1 billion for Q2 2016 at AbbVie, down from $1.1 billion in the prior quarter.
• Over five years, Work In Process peaked at $1.1 billion in Q1 2016 and troughed at $262.0 million in Q1 2013.
• A 5-year average of $672.0 million and a median of $568.0 million in 2015 frame the typical range for Work In Process.
• Across the five-year window, Work In Process jumped 122.85% in 2015 and rose 4.81% in 2016, its largest moves.
• Over 5 years, Work In Process stood at $286.0 million in 2012, then soared by 41.26% to $404.0 million in 2013, then soared by 55.69% to $629.0 million in 2014, then soared by 71.86% to $1.1 billion in 2015, then decreased by 1.2% to $1.1 billion in 2016.
• The last three Work In Process figures came in at $1.1 billion (Q2 2016), $1.1 billion (Q1 2016), and $1.1 billion (Q4 2015), per Business Quant data.